ImmuCell CEO Paul Francis Olivier te Boekhorst Acquires Common Shares
ImmuCell Corporation's CEO, Paul Francis Olivier te Boekhorst, has acquired common shares of the company. This event was reported through EDGAR by the U.S. Securities and Exchange Commission. The news is informational and not financial advice.
Paul Francis Olivier te Boekhorst, President and CEO of ImmuCell Corporation, has reported the acquisition of common shares of ImmuCell Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImmuCell Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-036794), on December 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
